(Q79260153)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14602752%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14602752%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis (English)

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

postmenopausal osteoporosis

29 March 2024

main subject

1 reference

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

29 March 2024

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

29 March 2024

author name string

John Fox

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14602752%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Robert Lindsay

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14602752%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Anthony B. Hodsman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602752

29 March 2024

David A. Hanley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602752

29 March 2024

Mark P. Ettinger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602752

29 March 2024

Michael A. Bolognese

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602752

29 March 2024

Anna J. Metcalfe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602752

29 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14602752

29 March 2024

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14602752%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

20 December 2019

published in

The Journal of Clinical Endocrinology and Metabolism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14602752%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14602752%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14602752%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

5212-5220

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14602752%20AND%20SRC:MED&resulttype=core&format=json

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

20 December 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

29 March 2024

2

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

29 March 2024

3

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

29 March 2024

4

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

29 March 2024

5

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

29 March 2024

6

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density

29 March 2024

7

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

29 March 2024

8

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Marked decrease in trabecular bone quality after five years of sodium fluoride therapy--assessed by biomechanical testing of iliac crest bone biopsies in osteoporotic patients

29 March 2024

9

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis

29 March 2024

10

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial.

29 March 2024

11

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84).

29 March 2024

12

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats

29 March 2024

13

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol

29 March 2024

14

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis

29 March 2024

15

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial

29 March 2024

16

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.

29 March 2024

17

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial

29 March 2024

18

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

29 March 2024

19

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Origin of parathyroid hormone (PTH) fragments detected by intact-PTH assays

29 March 2024

20

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

An intact N terminus is required for the anabolic action of parathyroid hormone on adult female rats

29 March 2024

22

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Binding of intact parathyroid hormone to rat osteosarcoma cells: major contribution of binding sites for the carboxyl-terminal region of the hormone

29 March 2024

23

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor

29 March 2024

26

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone

29 March 2024

27

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis

29 March 2024

28

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis

29 March 2024

29

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Parathyroid hormone and periosteal bone expansion

29 March 2024

30

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Comparison of rates of bone loss from the spine measured using two manufacturers' densitometers

29 March 2024

31

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis

29 March 2024

33

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Daily treatment with parathyroid hormone is associated with an increase in vertebral cross-sectional area in postmenopausal women with glucocorticoid-induced osteoporosis.

29 March 2024

34

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

Biomechanics of bone: determinants of skeletal fragility and bone quality

29 March 2024

35

1 reference

https://api.crossref.org/works/10.1210/JC.2003-030768

29 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14602752%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference